CVS Health Corp

NYSE: CVS
$61.61
+$6.27 (+11.3%)
Closing Price on November 6, 2024

CVS Articles

Tuesday’s top analyst upgrades, downgrades and initiations include Apple, CVS Health, Priceline, Teva Pharmaceutical and Workday.
CVS Health reported mixed fourth-quarter financial results before the markets opened on Thursday.
24/7 Wall St. has put together a preview of Coca-Cola, CVS Health and some of the other most anticipated quarterly earnings reports that are due on Thursday.
The top analyst upgrades, downgrades and initiations seen on Thursday, include Acacia, Facebook, Lululemon, Shutterfly, Transocean, United Rentals and Urban Outfitters.
If these Merrill Lynch sector picks provide total return and alpha, the upside potential for investors is outstanding.
Five companies with stocks rated Buy at Merrill Lynch and that do all of their business in the United States, which is critical, given the stronger dollar.
We found five Q-GARP stocks that could be solid 2017 winners, and four of them also pay solid dividends. All make good sense for growth portfolios with some risk tolerance.
24/7 Wall St. has screened the Merrill Lynch US 1 list and found five companies that could be poised to outperform in the coming year.
Monday’s top analyst upgrades, downgrades and initiations include Advanced Micro Devices, CVS Health, ConocoPhillips, EOG Resources, Seattle Genetics and WebMD.
Building on a turn toward more equity investments in the second quarter of this year, the top 50 hedge funds boosted their equity positions by nearly 3% in the third quarter.
Once Thanksgiving dinner is safely tucked away, many Americans' thoughts turn to shopping. Some will hit the stores that are open on the holiday and others may just browse through the offers online.
November 8, 2016: Here are four stocks trading with relatively heavy volume among 128 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by nearly 3 to 2...
October 28, 2016: Here are four stocks trading with relatively heavy volume among 138 equities making new 52-week lows in Friday’s session. On the NYSE, decliners led advancers by about 3 to 2 and...
A UBS research report notes the segments of the economy that may disproportionately benefit as all the money that baby boomers had stashed away in savings, pensions, IRAs and 401(k) plans starts to...
The UBS Dividend Ruler portfolio continues to outperform the overall market, and we continue to think that the outperformance will stay in place for the rest of the year and beyond.